Landos Biopharma

LABP NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $0 $0 $0
EBITDA -9,295 -6,310 -5,199 -4,399
EBIT -6,266 -4,439
Net Income -8,897 -6,119 -5,860 -3,922
Net Change In Cash 0 0 0 0
Free Cash Flow -8,498 -4,969 -2,228 -5,110
Cash 29,054 37,549 42,408 44,049
Basic Shares 6,207 6,207 6,207 6,207

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $0 $18,000 $18,000
Gross Profit -577 18,000 -137
EBITDA -22,727 -39,984 -38,620 -30,084
EBIT -40,561 -38,816 -30,676
Net Income -21,935 -37,991 -38,226 -30,144
Net Change In Cash 0 0 18,000 18,000
Free Cash Flow -20,477 -45,778 -27,501 -23,143
Cash 37,549 36,640 8,305 2,416
Basic Shares 6,275 4,025 4,025 4,011

Earnings Calls

Quarter EPS
2024-03-31 -$1.43
2023-12-31 -$0.99
2023-09-30 -$0.94
2023-06-30 -$0.63